Clinical Trial Update: Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 crossover trial of AD182 and AD504 for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AD182
• AD504

Snippet

Sponsor: Apnimed | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED